Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2024 07:00 ET | Source: Applied UV, Inc.

Applied UV Inc. Announces Receipt of Provisional Patent for Our Pulse Modulated UVC LED System to be Added to Our Patented Fighter Flex LED Solution Expanding Significant Revenue Opportunity

DENVER, CO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV Inc. (NASDAQ: AUVI), a leader in smart building technology solutions, announced the introduction of its industry...
August 01, 2023 07:30 ET | Source: Optimi Health Corp.

Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
March 14, 2023 09:00 ET | Source: AXIM Biotechnologies, Inc.

AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing

Leading Diagnostic Healthcare Company Announces Provisional Patent Filing on Proprietary Use of Materials for Ophthalmological Test Strip Manufacturing SAN DIEGO, CA, March 14, 2023 (GLOBE...
July 27, 2022 08:00 ET | Source: Medaro Mining Corp.

Medaro Provides Update on Technology Development and Field Exploration Programs

VANCOUVER, British Columbia, July 27, 2022 (GLOBE NEWSWIRE) -- Medaro Mining Corp. (CSE: MEDA) (OTC: MEDAF) (FWB: 1ZY) (“Medaro” or the “Company”), a multi-faceted venture aimed at developing...
January 18, 2022 09:00 ET | Source: Optimi Health Corp.

Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent

VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
March 22, 2021 06:18 ET | Source: Tauriga Sciences

Tauriga Sciences, Inc. Converts its U.S. Provisional Patent Application (Filed on March 17, 2020) to a U.S. Non-Provisional Patent Application

To Enhance Its Existing Intellectual Property Portfolio, the Company Filed an Additional U.S. Provisional Patent Application Directed to: Alternative Pharmaceutical Cannabinoid Delivery Systems NEW...
July 12, 2016 07:45 ET | Source: Zomedica

Zomedica Files U.S. Provisional Patent Application for Novel Pharmaceutical Formulation

ANN ARBOR, Mich., July 12, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company, today announced that it has filed a provisional application for...